1. India Stocks

  2. •

    Basic Materials

  3. •

    Agricultural Inputs
Nath Bio-Genes (India) Limited

Nath Bio-Genes (India) Limited

NATHBIOGEN.NS
Nath Bio-Genes (India) LimitedIN flagNational Stock Exchange of India
168.66
INR
+1.55
- -
3.21BMarket Cap

Total Valuation

Nath Bio-Genes (India) Limited carries a market capitalization of 3.21B, placing it among publicly traded companies globally. Its enterprise value stands at 1.47B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap3.21B
Enterprise Value1.47B

Share Statistics

Nath Bio-Genes (India) Limited currently has 19.00M shares outstanding.

Shares Outstanding19.00M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Nath Bio-Genes (India) Limited trades at a trailing price-to-earnings ratio of 5.95. The price-to-sales ratio is 0.56, and the price-to-book ratio stands at 13.04.

PE Ratio5.95
PS Ratio0.56
PB Ratio13.04
P/TBV Ratio0.37
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Nath Bio-Genes (India) Limited trades at an EV/EBITDA multiple of 3.03 and an EV/FCF ratio of 10.22. The EV/Sales ratio of 0.33 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 3.03 provides insight into valuation relative to core operating earnings.

EV / Sales0.33
EV / EBITDA3.03
EV / EBIT3.03
EV / FCF10.22

Financial Position

Nath Bio-Genes (India) Limited maintains a current ratio of 1.97, meaning it holds 2.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 20.35, indicating elevated leverage, while an interest coverage ratio of 3.03 demonstrates adequate ability to service its debt obligations.

Current Ratio1.97
Quick Ratio0.61
Debt / Equity20.35
Debt / EBITDA2.86
Interest Coverage3.03

Financial Efficiency

Nath Bio-Genes (India) Limited posts a return on equity of 16.19 and a return on invested capital of 5.54.

Return on Equity (ROE)16.19
Return on Assets (ROA)3.92
Return on Invested Capital (ROIC)5.54
Return on Capital Employed (ROCE)14.45
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover0.51

Taxes

Over the trailing twelve months, Nath Bio-Genes (India) Limited has paid 46.73M in income taxes, reflecting an effective tax rate of 10.09.

Income Tax46.73M
Effective Tax Rate10.09

Stock Price Statistics

Nath Bio-Genes (India) Limited's stock has declined approximately -24.225% over the past 52 weeks. The 50-day moving average sits at 170.02, while the 200-day moving average is 158.90.

Beta (5Y)N/A
52-Week Price Change-24.225%
50-Day Moving Average170.02
200-Day Moving Average158.90
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Nath Bio-Genes (India) Limited generated 4.45B in revenue and converted that into 416.30M in net income, yielding earnings per share of 21.68. EBITDA reached 484.74M, while operating income came in at 484.74M.

Revenue4.45B
Gross Profit2.44B
Operating Income484.74M
Pretax Income463.04M
Net Income416.30M
EBITDA484.74M
EBIT484.74M
Earnings Per Share (EPS)21.68

Balance Sheet

Nath Bio-Genes (India) Limited holds 2.39B in cash and equivalents against 1.39B in total debt, resulting in a net debt position of 625.06M. Total book value stands at 190.04M, with working capital of 3.84B providing operational flexibility.

Cash & Cash Equivalents2.39B
Total Debt1.39B
Net Debt625.06M
Equity (Book Value)190.04M
Book Value Per Share9.90
Working Capital3.84B

Margins

Nath Bio-Genes (India) Limited operates with a gross margin of 54.73, reflecting its pricing power and cost economics. The operating margin of 10.89 and net profit margin of 9.35 provide insight into operational efficiency.

Gross Margin54.73
Operating Margin10.89
Pretax Margin10.40
Profit Margin9.35
EBITDA Margin10.89

Scores

Nath Bio-Genes (India) Limited posts an Altman Z-Score of 1.33, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score1.33